Loading...
XSHG
600436
Market cap15bUSD
Nov 12, Last price  
182.23CNY
1D
1.31%
1Q
-9.76%
Jan 2017
298.14%
IPO
193.78%
Name

Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
P/E
36.93
P/S
10.19
EPS
4.93
Div Yield, %
1.27%
Shrs. gr., 5y
0.02%
Rev. gr., 5y
13.52%
Revenues
10.79b
+7.25%
418,820,927522,205,339593,069,218649,743,490694,749,846867,314,5831,021,565,7281,171,153,7381,395,868,5181,453,869,7711,885,674,6732,308,954,2693,713,953,9754,766,156,8935,722,273,4316,510,781,9578,021,550,4518,694,001,50410,058,497,33810,787,863,091
Net income
2.98b
+6.42%
86,398,28381,908,17595,188,986140,869,750129,663,236194,131,768254,867,961348,529,663429,768,408438,828,802466,676,722536,131,906807,018,6751,142,932,9171,374,376,8231,671,518,6672,431,899,9332,472,344,7312,797,351,5152,977,002,486
CFO
1.31b
-40.47%
69,055,60450,703,65460,038,07012,573,378129,519,043205,410,719232,950,354162,398,128274,336,209264,499,645305,510,311394,537,198676,933,316612,310,81801,467,076,541462,272,4046,873,030,5802,206,631,5191,313,708,033
Dividend
Jun 07, 20242.32 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhangzhou Pientzehuang Pharmaceutical., Ltd engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally. The company's products include medicines and health products, cosmetics, daily chemicals, medical apparatus and instruments, and health foods. The company is based in Zhangzhou, China. Zhangzhou Pientzehuang Pharmaceutical., Ltd is a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.
IPO date
Jun 16, 2003
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT